Meeting
2018 ASCO Annual Meeting
Impact of adjuvant chemotherapy in higher risk stage II colon cancer with a deficient mismatch repair (dMMR)/ microsatellite instability-high (MSI-H) profile.
Authors
AMR Mohamed
Karmanos Cancer Institute, Detroit, MI
AMR Mohamed , Renjian Jiang , Philip Agop Philip , Maria Diab , Madhusmita Behera , Christina Wu , Bassel F. El-Rayes , Mehmet Akce
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3604)
DOI
10.1200/JCO.2018.36.15_suppl.3604
Abstract #
3604
Poster Bd #
97
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Duration of FOLFOX adjuvant chemotherapy in high-risk stage II and stage III colon cancer with deficient DNA mismatch repair.
First Author: Zehua Wu
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Characteristics and outcomes of patients with multiple synchronous colon cancer primaries.
First Author: Maria Diab
Poster
2021 Gastrointestinal Cancers Symposium
Final results of the ACTS-CC 02 trial: A randomized phase III trial of S-1/oxaliplatin (SOX) versus UFT/leucovorin as adjuvant chemotherapy for high-risk stage III colon cancer.
First Author: Naohiro Tomita
Poster
2020 ASCO Virtual Scientific Program
Impact of tumor side on clinical outcomes in stage II and III colon cancer with known microsatellite instability status.
First Author: Katerina Mary Zakka